Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione and analogs

Authors:
  • Ivan Villax
Source:
GB 1397267

Pregnatrienedione I was prepd. from epoxypregnanetrione II in 7 steps. Thus, II underwent ketalization with HOCH2CH2OH, KBH4 redn., dehydration, Grignard reaction with MeMgBr, and deketalization to give pregnenedione III. III was treated with Br2-HOAc and then debrominated to I.

Also in the Knowledge Center

Related Content

ËÄÉ«AV and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions

Press Release / Sep 19, 2024
Article
View

Particle Engineering for Inhalation and Nasal

ËÄÉ«AV is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

Drug Product Manufacturing

To extend ËÄÉ«AV further we are now able to offer clinical supplies manufacturing for drug products.

Page
Read more